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The gut microbiota is amongst the most densely populated microbial ecosystem on earth.
While the microbiome exerts numerous health beneﬁcial functions, the high density of
micro-organisms within this ecosystem also facilitates horizontal transfer of antimicrobial
resistance (AMR) genes to potential pathogenic bacteria. Over the past decades antibiotic
susceptibility testing of speciﬁc indicator bacteria from themicrobiome, such asEscherichia
coli, has been the method of choice in most studies. These studies have greatly enlarged
our understanding on the prevalence and distribution of AMR and associated risk factors.
Recent studies using (functional) metagenomics, however, highlighted the unappreciated
diversity of AMR genes in the human microbiome and identiﬁed genes that had not
been described previously. Next to metagenomics, more targeted approaches such
as polymerase chain reaction for detection and quantiﬁcation of AMR genes within a
population are promising, in particular for large-scale epidemiological screening. Here we
present an overview of the indigenous microbiota as a reservoir of AMR genes, the current
knowledge on this “resistome” and the recent and upcoming advances in the molecular
diagnostic approaches to unravel this reservoir.
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INTRODUCTION
Antimicrobial resistance (AMR) is worldwide one of the most
important public health threats that we face currently. AMR
reduces clinical efﬁcacy and increases treatment costs. Further-
more, AMR jeopardizes the achievements of modern medicine,
since the success of interventions such as organ transplantation,
cancer chemotherapy, and major surgery depends on effective
antimicrobial agents for prevention and treatment of (nosoco-
mial) infections. With a lack of novel antibiotics in the pipeline,
the conservation of existing ones is crucial.
While the majority of studies on the epidemiology of antibiotic
susceptibility have been focused on clinical isolates, the human
microbiota warrants special attention as perhaps the most acces-
sible reservoir of resistance genes due to the high likelihood of
contact and genetic exchange with potential pathogens. Here we
present a non-comprehensive overview of the indigenous micro-
biota as a reservoir of AMR genes, the current knowledge on
this “resistome” and the recent and upcoming advances in the
molecular diagnostic approaches to unravel this reservoir.
THE HUMAN GUT MICROBIOTA
The human gut microbiota has long been recognized to con-
tribute to health and disease by inﬂuencing gut maturation, host
nutrition and pathogen resistance (Dethlefsen et al., 2006). More
recently, intestinal microbes have been shown to inﬂuence host
energymetabolism (Backhed et al., 2004), intestinal epithelial pro-
liferation (Rakoff-Nahoum et al., 2004) and immune responses
(Noverr and Huffnagle, 2004). As such, perturbations in the
microbiota composition have been linked to vaginosis (Ravel et al.,
2011), obesity (Ley et al., 2005), inﬂammatory bowel disease (IBD;
Neuman and Nanau, 2012), functional bowel disorders (Simren
et al., 2013), allergies (Penders et al., 2007), and other diseases
(Kinross et al., 2011).
The establishment of the indigenous microbiota starts as soon
as the amniotic membranes rupture and subsequently involves a
succession of bacterial populations waxing and waning as the diet
changes and the host develops.
The bacteria colonizing the infant gut during the ﬁrst days
of life originate mainly from the mother’s birth canal, the living
environment and from handling by other individuals. (Reid et al.,
2011). Vaginally born infants are colonized at ﬁrst by maternal
fecal and vaginal bacteria, whereas infants born through cesarean
section are exposed initially to bacteria originating from the hos-
pital environment and healthcare workers (Penders et al., 2006;
Dominguez-Bello et al., 2010).
Other factors that can inﬂuence the neonatal intestinal micro-
biota composition are: the environment during birth, prematurity,
hygiene measures, and the type of infant feeding (Penders et al.,
2005, 2006; Adlerberth et al., 2007; Azad et al., 2013). The new-
born’s gastrointestinal communities still have relatively few species
and lineages, but diversity increases rapidly over the ﬁrst year of
life (Palmer et al., 2007).
The majority of indigenous microbes cannot be cultivated,
and it’s only since the recent application of sequencing tech-
niques that the human microbiota has been described in all
complexity including the unculturable and rare taxa. Eckburg
et al. (2005) undertook a large comparative analysis of 16S rRNA
gene sequences, by means of conventional cloning and sequenc-
ing, to characterize the mucosal and fecal microbial communities
in three healthy individuals. Results demonstrated that bacterial
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diversity within the human colon and feces was far greater than
previously described, most of it being novel and uncultivated
(62 and 80% of identiﬁed phylotypes, respectively). Subsequent
studies using next-generation sequencing or micro-arrays target-
ing the 16S rRNA gene provided an even more in-depth picture
of our inner microbial ecosystem. These studies amongst others
demonstrated that the gut microbiota is dominated by the phyla
Bacteroidetes and Firmicutes and to a lesser extent Actinobacteria,
Proteobacteria, Verrucomicrobiae, and Fusobacteria (Dethlefsen
et al., 2006; Andersson et al., 2008; Zoetendal et al., 2008).
Although the individual microbial composition has an “indi-
vidual core” that varies on the phylotype level (Jalanka-Tuovinen
et al., 2011), the overall phylogenetic proﬁle canbe categorized into
three predominant variants, or “enterotypes,” dominated by Bac-
teroides, Prevotella, and Ruminococcus, respectively (Arumugam
et al., 2011). In a recent study among 98 individuals, enterotypes
were found to be strongly associated with long-term diets (Wu
et al., 2011).
A broad gene catalog of the human gut microbiome derived
from 124 adult subjects, generated by the international metage-
nomics of human intestinal tract (Meta-HIT) project, identiﬁed
a staggering number of some 3.3 million different bacterial genes
among the studied individuals, which is 150-foldmore than in our
own human genome. (Qin et al., 2010).
Next to the apparent beneﬁcial effects on human health, the
human microbiota warrants special attention as perhaps the most
accessible reservoir of antibiotic resistance given the high density
of micro-organisms within this ecosystem. The gastrointestinal
tract is an open system, which every day encounters a myriad
of bacterial acquisitions originating from the environment (e.g.,
from food, water, soil, and other humans or animals; Baquero,
2012). These incoming bacteria often harbor antibiotic resistance
genes. In case of opportunistic pathogens of environmental or
food-borne origin, such AMR bacteria can pose a direct threat to
the host. Alternatively, these incoming microbes might transfer
their resistance elements through horizontal gene transfer (HGT)
to the indigenousmicrobial communities. HGTcanoccur between
different species and genera, and as such between commensals and
(opportunistic) pathogens. Well-known examples are the CTX-M
extended-spectrumbeta-lactamase (ESBL) resistance genes,which
originate from Kluyvera species (Canton and Coque, 2006) or the
wide distribution of typeA streptogramin acetyltransferases across
bacterial species (Seoane and Garcia Lobo, 2000).
Therefore, it is crucial to study the AMR potential of natu-
ral environments, such as the indigenous microbiota, and not
merely as mechanisms already emerged in pathogens (Wright,
2010; Schmieder and Edwards, 2012).
ANTIMICROBIAL RESISTANCE IN INDICATOR
MICRO-ORGANISMS.
Until very recently, costs and limitations in the advancement of
molecular technology hampered the assessment of the AMR of
the microbiome as a whole. Instead, the antibiotic susceptibility
of indicator micro-organisms was assessed. Mostly, the choice of
the indicator micro-organism(s) was based on the clinical rele-
vance of these organisms; i.e., whether they were implicated in
causing infections, but also on the cultivability of these organisms
rather than for example those who represented the majority of the
microbiome. Cultivability has been of major importance because
even today, every method to assess antibiotic susceptibility (rather
than antibiotic resistance) involves culturing the micro-organism
(Okeke et al., 2011).
CULTURE-BASED ANALYSIS OF ANTIMICROBIAL SUSCEPTIBILITY
By far the greatest majority of studies to date on antimicrobial
susceptibility (AMS) of the gut microbiota have used (selective)
culturing and isolation of speciﬁc micro-organisms, followed
by culture-based antibiotic susceptibility testing to obtain their
results. Most of these studies focused on E. coli or enterococci
as indicator micro-organisms and they have gained invaluable
insights regarding: (i) geographic differences in AMS prevalence
and changes in prevalence over time (Nys et al., 2004); (ii) the
inﬂuence of population density and hospitalization (Jonkers et al.,
2002; Bruinsma et al., 2003a,b); and. (iii) the link between AMS
in food animals and humans (van den Bogaard and Stobberingh,
2000). Additionally, culture-based analysis of AMS of indicator
micro-organisms have demonstrated the relationship between the
AMS of fecal E. coli and that of E. coli implicated in infections such
as urinary tract infections (Lester et al., 1990; den Heijer et al.,
2012). Finally, culture-based studies have signiﬁcantly increased
our knowledge on the relationship between antibiotic use and
AMS of intestinal micro-organisms. It has been shown that antibi-
otic use is strongly correlated with the prevalence of resistant fecal
E. coli and other Gram-negatives (Murray et al., 1982; Bruinsma
et al., 2003c; van der Veen et al., 2009; and reviewed in Donskey,
2006), but also that resistance is emerging in populations with
minimal exposure to antibiotics such as in remote Indian com-
munities (Bartoloni et al., 2004; Grenet et al., 2004). These latter
ﬁndings implicated the role of transfer of resistant bacteria from
person-to-person or via food or the environment. To further study
the spreading of resistance through microbial communities or
from one person’s microbiota to another, molecular diagnostic
analysis was introduced.
MOLECULAR DIAGNOSTICS OF ANTIMICROBIAL RESISTANCE
In a follow-up study on the samples from a remote Indian com-
munity with minimal antibiotic exposure, Pallecchi et al. (2007)
used molecular genotyping as well as the characterisation of resis-
tance genes by polymerase chain reaction (PCR). This study
supported the hypothesis that emergence of resistance within
this community was due to the introduction of resistant strains
from antibiotic-exposed settings, followed by the local dissemi-
nation and maintenance of resistance. The analysis of resistance
genes by PCR and/or sequencing has also been extensively used
to monitor the spreading of ESBL-producing Enterobacteriaceae.
Several studies monitored changes in carriage of ESBL-producing
micro-organisms within different geographic areas and over time
(Overdevest et al., 2011; Geser et al., 2012; Gijon et al., 2012; Sev-
erin et al., 2012). PCR and sequencing analysis have also shed light
on the vehicles of transmissionof resistance. The role of resistance-
carrying integrons was identiﬁed after antibiotic treatment (Vinue
et al., 2008; van der Veen et al., 2009; Vo et al., 2010). Also, the role
of resistance-harboring plasmids in dissemination of resistance
was extensively studied (reviewed by Carattoli, 2009). In addition
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to the wealth of information that is currently still being discovered
by applying these techniques on indicator micro-organisms, it has
become clear that these methods can also be employed directly
to biological samples. This enables analysis of resistance genes
within the entire microbiota and investigates the so-called “resis-
tome” thereby avoiding the potential bias that is introduced when
selecting certain indicator micro-organisms.
METAGENOMICS TO CHARACTERIZE THE AMR RESERVOIR
Metagenomics, refers to the study of metagenomes, genetic
material recovered directly from environmental samples. It is
the genomic analysis (analysis of all the DNA in an organism)
applied to all the micro-organisms of a microbial ecosystem with-
out previous identiﬁcation (Lepage et al., 2013). Three different
metagenomic approaches have been applied to study the resistome:
targeted (PCR-based) metagenomics, functional metagenomics,
and sequence-based metagenomics.
TARGETED (PCR-BASED) METAGENOMICS
The accumulating evidence, showing that resistance genes are
transferred within an ecosystem and across species, has high-
lighted the potential of application of easy-to-use PCR-based
metagenomics. Numerous PCR methods are currently available
for the detection of resistance genes or gene families. Furthermore,
when real-time PCR is used to perform such analysis, (semi-
)quantitative results can be generated and the relative abundance
of resistance genes can be determined. This approach has been
used to study the emergence of resistance over time in soil and
water environments (Koike et al., 2007; Knapp et al., 2011). Knapp
et al. (2010) showed that resistance to beta-lactamases, tetracy-
clines, and erythromycins in soil collected over a period of 70 years,
signiﬁcantly increased. A similar approach was applied to study
the prevalence of resistance genes in oral bioﬁlms (Kim et al.,
2011) and very recently to study ﬂuoroquinolone resistance in
fecal samples of Vietnamese children (Vien le et al., 2012). The
main drawback to using targeted PCR-based metagenomics is
that the results are skewed towards known resistance genes and
mechanisms. Importantly, evidence is accumulating of convergent
evolution of resistance with different genes performing a similar
function (Deschamps et al., 2009). Furthermore, sequence hetero-
geneity within a resistance gene found in different species may
again skew the results towards mostly studied species. Nonethe-
less, the availability of this methodology within laboratories and
possibilities for high-throughput analysis at limited costs make
targeted (PCR-based) metagenomics a valuable tool in studying
the resistome.
FUNCTIONAL METAGENOMICS
Functional metagenomics, involves the cloning of DNA fragments
into a vector (e.g., a plasmid), and the subsequent expression into
heterologous hosts (often E. coli). Next, these transformants are
screened for the expression of resistance genes by growing themon
antibiotic containingmedia at concentrations where the wild-type
host strain is susceptible, where after antibiotic resistant clones are
being sequenced (Schmieder and Edwards, 2012).
Sommer et al. (2009) characterized the resistance reservoir in
saliva and fecal samples from two unrelated healthy individuals.
The microbiota of these individuals was analyzed by functional
screening of metagenomic DNA. Sequencing and annotation of
clones conferring resistance to 13 different antibiotics enabled the
discovery of 95 unique inserts containing functional antibiotic
resistance genes. The majority of these genes were evolutionar-
ily distant from known resistance genes, including 10 previously
unidentiﬁed beta-lactamase gene families. This might reﬂect the
existence of an unappreciated barrier between these bacteria with
novel resistance genes and readily cultured human pathogens
(Sommer et al., 2009, 2010; Schmieder and Edwards, 2012).
Recently a metagenomic library generated from the gut micro-
biota of four healthy humans was functionally screened for AMR
genes against seven antibiotics (Cheng et al., 2012). This study
conﬁrmed the suitability of functional metagenomics to recover
new AMR genes by identifying novel resistance genes against
amoxicillin, D-cycloserine, and kanamycin.
Next, to the application of functional screening for resistance
genes in the human microbiota, this approach has been used to
detect the resistance reservoir in the gut microbiota of amongst
others honeybees (Tian et al., 2012), chickens (Zhou et al., 2012),
and gulls (Martiny et al., 2011).
One of the main limitations of functional screening is the
dependence upon each gene’s ability to be expressed in surro-
gate hosts, typically E. coli. Resistance genes not being expressed
by the surrogate host, e.g., because multiple genes are required
that work together, regulatory elements are not being recognized,
or posttranslational modiﬁcations are missing, leave these genes
unidentiﬁed (false negatives). On the other hand the foreign gene
may as well interact in novel ways with the cellular machinery
of the surrogate host resulting in false positives (Schmieder and
Edwards, 2012).
SEQUENCE-BASED METAGENOMICS
In sequence-based metagenomics, DNA from an environmental
sample is extracted, fragmented and size-separated, and randomly
sequenced directly, without the need for culturing. The metage-
nomic sequences can subsequently be compared to international
sequence databases to identify resistance genes (Schmieder and
Edwards, 2012). The transition from Sanger sequencing to next-
generation sequencing platforms (i.e., the Roche 454 sequencer,
theGenomeAnalyzer of Illumina and the SOLiD systemofApplied
Biosystems) has resulted in a dramatic drop in costs and con-
sequently have increased the number and size of metagenomic
sequencing projects. These sequencing technologies yield lower
contiguous read lengths and require greater genome coverage;
however, their high-throughput reduces consumable costs and
number of sequencing runs (Niedringhaus et al., 2011). Although
the number of studies applying sequence-based metagenomics to
characterize the human gut microbiome is rapidly growing, to our
knowledge none of these studies speciﬁcally focussed on the AMR
genes. Yet, the submission of these metagenomic libraries in pub-
lic databases enables the in silico analysis of resistance elements
within these studies.
Resistant bacteria from animals, zoonotic bacteria or intesti-
nal commensals, can infect or reach the human population not
only by direct contact, but also via food products of animal ori-
gin (van den Bogaard and Stobberingh, 2000) and through the
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application of animal feces as fertilizer in agriculture. As such,
several studies have applied sequence-based metagenomics to
characterize the virulence-associated and AMR genes in amongst
others buffalo rumen (Singh et al., 2012), cattle feces (Durso
et al., 2011), swine feces (Looft et al., 2012), and chicken cecum
(Qu et al., 2008).
Over six percent (6.44%) of the sequences of the buffalo
metagenomic library (Singh et al., 2012) and over eight percent
(8.4%) of the sequences from the cattle fecal pool (Durso et al.,
2011) couldbemapped to virulence genes using the SEEDdatabase
functional gene categories. In both datasets almost half of these
sequences were associated with resistance to antibiotic and toxic
compounds (RATC), the most frequently occurring functional
group being multidrug resistance efﬂux pumps followed by ﬂuo-
roquinolone resistance. The ﬂuoroquinolone resistance genes are
of particular interest because there is concern that the use of this
class of antibiotics in veterinary medicine, particularly for food
animals, may contribute to the development of resistance to this
class of antibiotics in humans (Durso et al., 2011). Singh et al.
(2012) compared their own buffalo rumen metagenomic dataset
with datasets of amongst others cattle feces, cattle rumen, chicken
cecum, and human stool (Figure 1). The multidrug resistance
efﬂux pump and ﬂuoroquinolone resistance were also the pre-
dominantRATC functional groups in the cattle rumenand chicken
cecum libraries, whereas the ﬂuoroquinolone resistance was less
abundant in the human stool library.
FIGURE 1 | Comparison of relative abundance of RATC genes in publicly
available metagenomic datasets of human stool (MG-RAST #4444130.3),
Cattle feces (MG-RAST #4448367.3), Buffalo Rumen (MG-RAST
#4446901.3), Cow rumen (MG-RAST #4441679.3), and Chicken Cecum
(MG-RAST #4440283.3). Data were derived from Singh et al. (2012).
Sequences were annotated using the SEED database functional gene
categories under the metagenome rapid annotation using subsystem
technology (MG-RAST).
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As plasmids are important mediators of HGT of AMR
genes, a more focussed sequencing of the plasmid metagenome
(plasmidome/metamobilome) has also been applied (Walker,
2012).
Although with traditional metagenomic sequencing every sin-
gle extra-chromosomal element within an environment can be
sequenced (as long as the sequencing depth is sufﬁcient), the pro-
portion of chromosomal and extra-chromosomal genomes will
always remain hugely in favor of chromosomes resulting inmasses
of redundant data when one is merely interested in the extra-
chromosomal metagenome (Li et al., 2012) The research on the
plasmidome is only in its infancy and has been applied to very few
environments to date.
As described above, many resistance genes identiﬁed in studies
applying functional metagenomics have low similarity to known
genes. In sequence-based metagenomics, sequences with low sim-
ilarity to known reference sequences cannot be easily identiﬁed, in
other words this approach is generally limited to identifying genes
that are already known (Schmieder andEdwards,2012). The anno-
tation power of sequence-basedmetagenomics will, however, keep
improving, as long as functional metagenomic-based studies keep
identifying novel AMR genes.
In addition, sequence-based metagenomics does not provide
any information on the expression of the identiﬁed genes. On
the other hand, sequence-based metagenomics provides a wealth
of information not only on AMR genes, but on the entire gene
content thereby enabling the identiﬁcation of the community
composition and metabolic proﬁle. In particular these metage-
nomic data sets enable to look at which members of the bacterial
community are carrying particular functional genes.
CONCLUSION
Previous research on marker gut microbes has provided a wealth
of information on amongst others AMS of these strains in dif-
ferent hosts, over time and at different geographic locations. In
the current era of molecular techniques, there is still a place for
culture-based studies as it is a necessity to assess antibiotic suscep-
tibility. Yet, targeted, functional, or sequence-basedmetagenomics
are required to gain more insight in the potential of the human
gut microbioma as an AMR reservoir. These techniques have their
own strengths and limitations and application of these techniques
in population-based studies is only starting to emerge. Within the
coming years, newmetagenomics-based studies are likely to reveal
many novel insights into this subject.
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